Edition:
United Kingdom

Koninklijke DSM NV (DSMN.AS)

DSMN.AS on Amsterdam Stock Exchange

75.52EUR
4:35pm GMT
Change (% chg)

€0.82 (+1.10%)
Prev Close
€74.70
Open
€75.32
Day's High
€75.90
Day's Low
€74.36
Volume
612,344
Avg. Vol
775,926
52-wk High
€93.04
52-wk Low
€73.36

Chart for

About

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in offering health, nutrition and materials. The Company's segments include Nutrition, Performance Materials, Innovation Center and Corporate Activities. Its Nutrition segment includes DSM Nutritional Products and DSM Food Specialties. Its Performance... (more)

Overall

Beta: 0.83
Market Cap(Mil.): €12,599.97
Shares Outstanding(Mil.): 181.43
Dividend: 0.58
Yield (%): 2.56

Financials

  DSMN.AS Industry Sector
P/E (TTM): 16.53 15.35 337.36
EPS (TTM): 4.20 -- --
ROI: 5.62 7.49 10.55
ROE: 13.12 11.78 13.70

UPDATE 1-DSM Q3 core profit rises 11 pct on higher vitamin prices

AMSTERDAM, Oct 31 Dutch speciality chemicals company DSM on Wednesday beat analyst expectations with an 11-percent rise in third-quarter core profit, to 406 million euros ($460.4 million), helped by elevated vitamin prices and higher sales.

31 Oct 2018

DSM Q3 core profit rises 11 pct on higher vitamin prices

AMSTERDAM, Oct 31 Dutch speciality chemicals company DSM on Wednesday beat analyst expectations with an 11-percent rise in third-quarter core profit, to 406 million euros ($460.4 million), helped by elevated vitamin prices and higher sales.

31 Oct 2018

UPDATE 1-DSM's Q2 core profit surges 35 pct on vitamin boost; confirms outlook

AMSTERDAM, Aug 1 Dutch speciality chemicals company DSM on Wednesday said second-quarter core profit surged 35 percent to 508 million euros ($593.2 million), boosted by exceptionally high vitamin prices and cost cuts.

01 Aug 2018

DSM's Q2 core profit rises 35 pct on vitamin boost

AMSTERDAM, Aug 1 Dutch specialty chemicals company DSM on Wednesday said second-quarter core profit rose 35 percent to 508 million euros ($593.2 million), helped by elevated vitamin prices and cost cuts.

01 Aug 2018

Earnings vs. Estimates